Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
12/2005
12/22/2005WO2005121343A1 Construction of oncolytic adenovirus recombinant specifically expressing immune modulatory factor gm-csf in tumor cells and uses thereof
12/22/2005WO2005121340A1 Novel galectin 8 modification protein and use thereof
12/22/2005WO2005121166A1 Novel immunointeractive molecules and uses thereof
12/22/2005WO2005121135A1 Vla-4 inhibitor
12/22/2005WO2005121095A1 Pyridine analogs as c5a antagonists
12/22/2005WO2005120577A2 Derivatives of chemotherapeutic agents with a formaldehyde releasing moeity
12/22/2005WO2005120574A1 Drug having regulatory cell ligand contained in liposome
12/22/2005WO2005120560A1 Bacterial compositions for the treatment of cancer
12/22/2005WO2005102999A3 Crystalline forms of fexofenadine hydrochloride and processes for their preparation
12/22/2005WO2005097814A3 Composition and method for inhibiting platelet aggregation
12/22/2005WO2005046569A3 Pharmaceutical compositions for the treatment of sars
12/22/2005WO2004105789A8 Grf analog compositions and their use
12/22/2005WO2004058159A3 Branched immunomodulatory compounds and methods of using the same
12/22/2005WO2003057856A3 Dominant negative proteins and methods thereof
12/22/2005US20050283844 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
12/22/2005US20050282900 Inhibitors of alpha4 mediated cell adhesion
12/22/2005US20050282882 Diamines as modulators of chemokine receptor activity
12/22/2005US20050282881 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
12/22/2005US20050282880 Novel 1H-indazole compounds
12/22/2005US20050282876 Inhibitors of IMPDH enzyme
12/22/2005US20050282866 2,3-Diphenyl-1H-indole-5-carboxylic acid; I kappa B kinase inhibitor; decrease activation of nuclear factor (NF) kappa B; antiinflammatory agent: arthritis, osteoarthritis, asthma, cardiac infarct, Alzheimer's disease, carcinomateous disorders or atherosclerosis
12/22/2005US20050282861 Sulfonamide-containing benzene derivatives; cancer and inflammatory, immunomodulatory or respiratory diseases; allergy, seasonal allergic rhinitis, reversible airway obstruction, adult respiratory distress syndrome, asthma, or bronchitis
12/22/2005US20050282838 Compounds, compositions, and methods
12/22/2005US20050282798 Pharmaceutical compounds
12/22/2005US20050282796 Tetracyclic azepinoindole compounds
12/22/2005US20050282789 administering for treatment of metabolic bone diseases, mobilizing calcium for osteoporosis, imbalances in the immune system
12/22/2005US20050282762 Antisense oligonucleotides for treating atopic diseases and neoplastic cell proliferation
12/22/2005US20050282742 Such as bortezomib, by freeze drying
12/22/2005US20050282236 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
12/22/2005US20050282223 TR3-specific binding agents and methods for their use
12/22/2005US20050282216 Purified polypeptides having IL-13 receptor activity
12/22/2005US20050281843 Use of bioadhesives and adjuvants for the mucosal delivery of antigens
12/22/2005US20050281836 Synthetic vaccine for tick control
12/22/2005US20050281824 Methods of using IMXP-888 and IMXP-888 antagonists
12/22/2005US20050281818 Method for the treatment of fibrosis
12/22/2005US20050281817 Method for treating multiple sclerosis
12/22/2005US20050281794 comprising a catechin (epigallocatechin gallate), an anti-oxidant (ascorbic acid), proline and lysine; cancer
12/22/2005US20050281793 T cell activation
12/22/2005US20050279350 Methods and apparatus for relieving headaches, rhinitis and other common ailments
12/22/2005CA2611377A1 Bacterial compositions for the treatment of cancer
12/22/2005CA2569836A1 Herbal compositions for prevention and treatment of rheumatic and inflammatory diseases and method of preparing the same
12/22/2005CA2569590A1 Drug having regulatory cell ligand contained in liposome
12/22/2005CA2569406A1 Methods for treating mast cell disorders
12/22/2005CA2569137A1 Intranasal formulations of interferon beta free of stabilizers that are proteins or polypeptides
12/22/2005CA2568995E Construction of oncolytic adenovirus recombinant specifically expressing immune modulatory factor gm-csf in tumor cells and uses thereof
12/22/2005CA2568673A1 Pyridine analogs as c5a antagonists
12/21/2005EP1607095A1 Antipruritic composition for external use on skin
12/21/2005EP1606314A2 Fc REGION VARIANTS
12/21/2005EP1606265A1 2, 4- di (phenylamino) pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders
12/21/2005EP1606258A1 Cathepsin s inhibitors
12/21/2005EP1605966A1 Use of chemokine receptor agonists for stem cell transplantation
12/21/2005EP1605963A2 Inhibitors of antigen presentation by mhc class ii molecules and methods of use thereof
12/21/2005EP1605946A2 Thiazoles useful as inhibitors of protein kinases
12/21/2005EP1605943A2 1-amino 1h-imidazoquinolines
12/21/2005EP1576086A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
12/21/2005EP1463728A4 Fused cyclic modulators of nuclear hormone receptor function
12/21/2005EP1458723A4 Fused heterocyclic succinimidecompounds and analogs thereof, modulators of nuclear hormone receptor function
12/21/2005EP1377567B1 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists
12/21/2005EP1363897B1 Antagonists of mcp-1 function and methods of use thereof
12/21/2005EP1335931B1 Derivatisation of proteins in aqueous solution
12/21/2005EP1313738B1 Process for the preparation and purification of thiol-containing maytansinoids
12/21/2005EP1265916B1 Therapeutic anti-cytomegalovirus compounds
12/21/2005EP1265859B1 Amidino compounds useful as nitric oxide synthase inhibitors
12/21/2005EP1223915B1 Dry powder compositions having improved dispersivity
12/21/2005EP1218518B1 Dna polymerase lambda and uses thereof
12/21/2005EP1144431B1 16-hydroxyestratrienes as selective estrogens
12/21/2005EP0994947B1 Mu-1, member of the cytokine receptor family
12/21/2005EP0783573B1 Method of enhancing expression of mhc class i molecules bearing endogenous peptides
12/21/2005EP0702692B1 Regulation of antigen presentation
12/21/2005EP0680331B1 Recombinant virus immunotherapy
12/21/2005CN1711235A New phenyl-naphthalene derivatives, and preparation method and drug containing same
12/21/2005CN1232563C Poly acid anhydride for release-controlled medicine carrier and method for producing the same
12/21/2005CN1232539C Match of organic medicine and beta-cyclodextrin derivative and its preparing process
12/21/2005CN1232507C Growth hormone secretagogues
12/21/2005CN1232503C Propenecarboxylic acid amidoxime derivatives, process for preparation thereof, and pharmaceutical compositions containing same
12/21/2005CN1232302C Compound preparation of Azithromycin and Pidotimod
12/21/2005CN1232256C Application of N-acetylglucosamine in preparation of medicine for treating local injure or whole body syndrome due to self immune reaction
12/20/2005US6977268 Diacid isoindoleine amide derivative
12/20/2005US6977267 Spiro-hydantoin compounds useful as anti-inflammatory agents
12/20/2005US6977266 Pyridone derivatives having affinity for cannabinoid 2-type receptor
12/20/2005US6977264 For therapy and prophylaxis of obesity, diabetes
12/20/2005US6977263 Chemical compounds
12/20/2005US6977255 8-Substituted 2-morpholinyl-4H-pyrido(1,2-a)pyrimidin-4-ones inhibitor of phosphoinositide (PI) 3- kinase, an enzyme that regulates platelet-adhesion (antithrombotic agent)
12/20/2005US6977076 Immunomoderators; high molecular weight polysaccharides
12/20/2005US6977071 Use for treatment of inflammatory diseases, HIV-infection, angiogenisis and hematopoiesis-related disorders;
12/20/2005CA2324324C Treatment of pulmonary hypertension
12/20/2005CA2266319C Isolated nucleic acid molecule encoding cancer associated antigen, the antigen itself, and uses thereof
12/15/2005WO2005118672A1 Polymer based nano-carriers for the solubilization and delivery of hydrophobic drugs
12/15/2005WO2005118559A1 A type of formyl peptide receptor-like 1 regulator, preparation method and use thereof
12/15/2005WO2005118543A1 Kinase inhibitor and use thereof
12/15/2005WO2005117860A1 Method of treating and preventing arthritis, cutaneous and cardiovascular inflammatory-related diseases using nicotinic receptor agonists
12/15/2005WO2005079506A3 Systemic immune activation method using nucleic acid-lipid complexes
12/15/2005WO2005033145A8 Antibodies to nik, their preparation and use
12/15/2005WO2004064787A3 Parenteral formulations of peptides for the treatment of systemic lupus erythematosus
12/15/2005WO2002083855A3 Novel streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof
12/15/2005US20050277773 Pyrrolopyrimidine derivatives
12/15/2005US20050277646 N-[4-({5-(4-fluorophenyl)-4-[4-(trifluoromethyl)phenyl]pyridin-2-yl}oxy)-1,3-benzothiazol-2-yl]acetamide; vanilloid (capsaicin) receptor antagonist/agonist; antiinflammatory, analgesic, antiarthritis, antirheumatic; diseases involving sensory nerve function
12/15/2005US20050277644 Pyridine analogs as C5a antagonists
12/15/2005US20050277627 Colchinol derivatives as vascular damaging agents
12/15/2005US20050277609 Immunostimulatory nucleic acid molecules
1 ... 522 523 524 525 526 527 528 529 530 531 532 533 534 535 536 537 538 539 540 541 542 ... 1172